Elevation of autophagy markers in Sjögren syndrome dry eye

Sci Rep. 2017 Dec 8;7(1):17280. doi: 10.1038/s41598-017-17128-0.

Abstract

Autophagy is known to be implicated in the pathogenesis of Sjögren syndrome (SS), but evidences are limited. We aimed to examine the levels of autophagy markers in tear film and conjunctival epithelial cells from SS dry eye patients, and analyze their correlations with clinical features. Patients with SS dry eye exhibited lower Schirmer values, lower tear breakup time, and higher ocular staining scores. In tears, ATG5 and LC3B-II/I levels were significantly higher in SS dry eye. ATG5 and LC3B-II mRNA in the conjunctiva were also elevated in SS dry eye compared with non-SS dry eye. The immunostaining of conjunctival epithelium showed a punctate pattern of ATG5 and LC3B-II in SS dry eye. These staining patterns were also observed in the lacrimal gland of SS animal models. ATG5 levels in tears and the conjunctival epithelium strongly correlated with ocular staining scores, and one month of topical corticosteroid treatment reduced both ATG5 and LC3B-II/I levels in tear film and the conjunctival epithelium of patients with SS dry eye. Our results suggest that autophagy is enhanced or dysregulated in SS and autophagy markers may be serve as both diagnostic and therapeutic biomarkers in SS dry eye.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / pharmacology
  • Adult
  • Aged
  • Autophagy* / drug effects
  • Biomarkers / metabolism
  • Dry Eye Syndromes / complications*
  • Dry Eye Syndromes / metabolism
  • Dry Eye Syndromes / pathology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Sjogren's Syndrome / complications*
  • Tears / drug effects

Substances

  • Adrenal Cortex Hormones
  • Biomarkers